ClinicalTrials.Veeva

Menu

Polymorphonuclear Cells' Sensitivity to Aggregatibacter Actinomycetemcomitans Bacteria in Patients With Aggressive Periodontitis

P

Polak David

Status

Unknown

Conditions

Periodontal Disease

Treatments

Other: blood extraction

Study type

Interventional

Funder types

Other

Identifiers

NCT02010307
davidp-HMO-CTIL

Details and patient eligibility

About

aggressive periodontitis is an inflammatory disease which damage the teeth supporting structures mostly in young patients. and has genetic basis.

a specific bacteria: Aggregatibacter actinomycetemcomitans (Aa) is associated with this disease, and found to damage leukocytes by using a specific leukotoxin.

in the research the investigators are aiming to find molecular and immunological basis to aggressive periodontitis.

Enrollment

75 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients in periodontal department
  • healthy
  • diagnosed with chronic/aggressive periodontal disease
  • interested in participating the research

Exclusion criteria

  • diagnosed with diabetes, heart disease, immunosuppression, thrombocytopenia, clotting enzyme deficiency.
  • using alcohol, or drugs
  • pregnancy

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 3 patient groups

aggressive periodontitis
Experimental group
Description:
25 patients with aggressive periodontitis blood extraction
Treatment:
Other: blood extraction
chronic periodontitis
Experimental group
Description:
25 patients with chronic periodontitis blood extraction
Treatment:
Other: blood extraction
healthy
Experimental group
Description:
25 healthy periodontal patients blood extraction
Treatment:
Other: blood extraction

Trial contacts and locations

1

Loading...

Central trial contact

Hadas Lemberg, PhD; David Polak, DMD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems